List of abbreviations:
HM2: Heartmate 2
HM3:Heartmate 3
LVAD: Left Ventricular assist device
NYHA: New York Heart Association
LV: Left ventricle
1. Hanke JS, Dogan G, Zoch A, Ricklefs M, Wert L, Feldmann C, et al.
One-year outcomes with the HeartMate 3 left ventricular assist device. J
Thorac Cardiovasc Surg. 2018;
2. Beyazpınar DS, Ersoy Ö, Gültekin B, Aliyev A, Avsever M, Akay HT, et
al. Treatment of left ventricular assist device thrombosis:
Single-center experience. Exp Clin Transplant. 2018;
3. Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J,
Ransom J, et al. Association of Clinical Outcomes with Left Ventricular
Assist Device Use by Bridge to Transplant or Destination Therapy Intent:
The Multicenter Study of MagLev Technology in Patients Undergoing
Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3)
Randomized Clinical Trial. JAMA Cardiol. 2020;
4. Hanke JS, Dogan G, Wert L, Ricklefs M, Heimeshoff J, Chatterjee A, et
al. Left ventricular assist device exchange for the treatment of
HeartMate II pump thrombosis. J Thorac Dis. 2018;
5. Verdoorn BP, Luckhardt AJ, Wordingham SE, Dunlay SM, Swetz KM.
Palliative Medicine and Preparedness Planning for Patients Receiving
Left Ventricular Assist Device as Destination Therapy—Challenges to
Measuring Impact and Change in Institutional Culture. J Pain Symptom
Manage. 2017;
6. Kitahara H, Ota T. Left ventricular assist device explant versus
decommission for myocardial recovery. Journal of Thoracic and
Cardiovascular Surgery. 2017.
7. Baldwin ACW, Sandoval E, Letsou G V., Mallidi HR, Cohn WE, Frazier
OH. Surgical approach to continuous-flow left ventricular assist device
explantation: A comparison of outcomes. J Thorac Cardiovasc Surg. 2016;